Naltrexone and Pharmacy Benefit Management

ISSN： 1055-0887

Source： Journal of Addictive Diseases, Vol.23, Iss.4, 2004-06, pp. : 11-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Usefulness of pharmacoeconomics for pharmacy benefit management

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 349, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Pharmacy Benefit Management: Enhancing the Applicability of Pharmacoeconomics for Optimal Decision Making

By Mullins C.D.

PharmacoEconomics, Vol. 20, Iss. 1, 2002-01 ,pp. : 9-21

Adis International

Access to resources Recommend Favorite

Pharmacy benefit reduces out-of-pocket cost for ustekinumab

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 651, 2012-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Management of an opioid-impaired anaesthetist by implantable naltrexone

By Hulse Gary O'Neil George Arnold-Reed Diane

Journal of Substance Use, Vol. 9, Iss. 2, 2004-04 ,pp. : 86-90

Radcliffe Press

Access to resources Recommend Favorite

Efficacy and Tolerability of Naltrexone in the Management of Alcohol Dependence

Current Pharmaceutical Design, Vol. 16, Iss. 19, 2010-06 ,pp. : 2091-2097

Bentham Science Publishers

Access to resources Recommend Favorite